Breaking Boundaries In Cancer Treatment: IN8Bio & Their Revolutionary Approach Harnessing Gamma-Delta T Cells At Benzinga's Virtual Healthcare Summit
- last month
IN8bio was founded with the mission of developing novel therapies to address cancer. The company focuses on the development of cellular therapies using gamma-delta T cells, the “unconventional” T cell and is advancing a pipeline of autologous, allogeneic and genetically modified product candidates for both liquid and solid tumors.